Jones Financial Companies
RGNX icon

Jones Financial Companies’s Regenxbio RGNX Stock Holding History

Jones Financial Companies’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.6K Buy
8,550
+80
+0.9% +$664 ﹤0.01% 2895
2026
Q1 		$65.7K Buy
8,470
+4,200
+98% +$44.1K ﹤0.01% 2841
2025
Q4 		$61.5K Buy
4,270
+137
+3% +$1.71K ﹤0.01% 2429
2025
Q3 		$39.9K Buy
4,133
+1,270
+44% +$11.2K ﹤0.01% 2471
2025
Q2 		$24K Hold
2,863
– – ﹤0.01% 2516
2025
Q1 		$22.4K Hold
2,863
– – ﹤0.01% 2388
2024
Q4 		$22.1K Buy
+2,863
New +$26.9K ﹤0.01% 2214

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Jones Financial Companies's RGNX Position: Q2 2026 in Review

Jones Financial Companies increased its Regenxbio (RGNX) stake by 0.94% in Q2 2026, buying an estimated $664 and bringing the position to 8,550 shares worth $89.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2895.

Jones Financial Companies first reported a position in RGNX in Q4 2024 and has held it in 7 quarters since. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Jones Financial Companies held 8,550 shares of Regenxbio worth $89.6K as of Q2 2026.
  • Jones Financial Companies bought 80 Regenxbio shares in Q2 2026, an estimated $664.
  • Regenxbio made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2895 holding.
  • Jones Financial Companies first reported a position in Regenxbio in Q4 2024 and has held it in 7 quarters since.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.